Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis

Clinical trial NCT03431896 · COMPLETED

Trial details

NCT number: NCT03431896
Sponsor: The Cleveland Clinic
Status: COMPLETED
Study type: OBSERVATIONAL

Amyloidosis Amyloid Amyloid Neuropathies, Familial Amyloid Cardiomyopathy Amyloid - Primary Transthyretin Amyloidosis AL Amyloidosis

Start date: 2018-02-01
Primary completion: 2026-03-09
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.